- Home
- OPTT vs SBFM Comparison
OPTT vs SBFM Comparison
Compare OPTT & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- SBFM
- Stock Information
- Founded
- OPTT 1984
- SBFM 2006
- Country
- OPTT United States
- SBFM United States
- Employees
- OPTT N/A
- SBFM N/A
- Industry
- OPTT Electric Utilities: Central
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- OPTT Utilities
- SBFM Health Care
- Exchange
- OPTT Nasdaq
- SBFM Nasdaq
- Market Cap
- OPTT 17.2M
- SBFM 3.7M
- IPO Year
- OPTT 2007
- SBFM N/A
- Fundamental
- Price
- OPTT $0.16
- SBFM $3.14
- Analyst Decision
- OPTT
- SBFM
- Analyst Count
- OPTT 0
- SBFM 0
- Target Price
- OPTT N/A
- SBFM N/A
- AVG Volume (30 Days)
- OPTT 3.7M
- SBFM 90.8K
- Earning Date
- OPTT 12-11-2024
- SBFM 11-11-2024
- Dividend Yield
- OPTT N/A
- SBFM N/A
- EPS Growth
- OPTT N/A
- SBFM N/A
- EPS
- OPTT N/A
- SBFM N/A
- Revenue
- OPTT $5,554,000.00
- SBFM $30,481,982.00
- Revenue This Year
- OPTT N/A
- SBFM $86.70
- Revenue Next Year
- OPTT N/A
- SBFM $126.76
- P/E Ratio
- OPTT N/A
- SBFM N/A
- Revenue Growth
- OPTT 68.81
- SBFM 109.82
- 52 Week Low
- OPTT $0.12
- SBFM $2.42
- 52 Week High
- OPTT $0.57
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- OPTT 45.96
- SBFM 52.62
- Support Level
- OPTT $0.14
- SBFM $2.85
- Resistance Level
- OPTT $0.17
- SBFM $3.05
- Average True Range (ATR)
- OPTT 0.01
- SBFM 0.14
- MACD
- OPTT 0.00
- SBFM 0.03
- Stochastic Oscillator
- OPTT 66.67
- SBFM 85.29
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.